RGFP966 - 10mM in DMSO , Inhibitor of histone deacetylase 3, CAS No.1396841-57-8, Inhibitor of histone deacetylase 3

CAS: 1396841-57-8 Cat. No.: R409147 Formule: C₂₁H₁₉FN₄O Poids moléculaire: 362.4 PubChem CID: 56650312

GRADE & PURITY 10mM in DMSO

Synonyms

2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E)-

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Vue d’ensemble

Information

RGFP966 is anHDAC3inhibitor withIC50of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.
In vitro

RGFP966 is a slow-on/slow-off, competitive tight-binding HDAC inhibitor, with an IC50 of 0.08μM for HDAC3 and no effective inhibition of any other HDAC at concentrations up to 15μM. RGFP966 treatment on two CTCL cell lines for 24 hours prior to western blot analysis resulted in increased acetylation at H3K9/K14, H3K27, and H4K5, but not H3K56ac. RGFP966 decreases cell growth in CTCL (cutaneous T cell lymphoma) cell lines due to increased apoptosis that is associated with DNA damage and impaired S phase progression. RGFP966 causes a significant reduction in DNA replication fork velocity within the first hour of drug treatment.

In vivo

RGFP966 treatment (10 mg/kg) enhances long-term memory for object memory. RGFP966 (3 or 10 mg/kg, s.c.) facilitates extinction and prevents reinstatement of cocaine- conditioned place preference.
Cell Data

cell lines：

Concentrations：~10μM

Incubation Time：24 to 72 h

Powder Purity:≥99%

Specifications

Synonymes

2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E)-

Spécifications et pureté

10mM in DMSO

Mécanismes biochimiques et physiologiques

RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.

Conditions de stockage de stockage

Store at -80°C

Expédié en

Dry ice packs + Cold packs

Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.

Type d'action

INHIBITOR

Mécanisme d'action

Inhibitor of histone deacetylase 3

Noms et identifiants

• Isomères SMILES: C1=CC=C(C=C1)/C=C/CN2C=C(C=N2)/C=C/C(=O)NC3=C(C=C(C=C3)F)N
• CAS alternatif: 1357389-11-7
• PubChem CID: 56650312
• Termes d'entrée MeSH: RGFP966
• Poids moléculaire: 362.4

Cibles associées (humaines)

HDAC3 Tclin Histone deacetylase 3 (0 Activities)

Discover Target: HDAC3

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Propriétés chimiques et physiques

• Solubilité: Solubility (25°C) In vitro DMSO: 69 mg/mL (202.09 mM); Water: Insoluble; Ethanol: Insoluble

Références

1. Zongxin Zhu, Ximiao Chen, Hanwen Zhang, Ronghui Miao, Huiling Yu, Shiying Zhao, Youli Zhang, Tanxin Yu, Di Zhang, Yifei Zhou, Xiaolei Zhang, Wei Zhang.  (2026)  Lactate-driven H3K27 lactylation promotes Olig2-dependent remyelination and motor recovery after spinal cord injury.  NEUROPHARMACOLOGY,      [PMID:41525841] [10.1016/j.neuropharm.2026.110832]